MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Deep brain stimulation (DBS)"

  • 2016 International Congress

    Clinical effects of pallidal stimulation in dystonia are quantitatively related to intracortical inhibition

    A. Fecíková, V. Cejka, V. Capek, F. Ruzicka, V. Bocek, D. Štastná, I. Štetkárová, D. Urgošík, R. Jech (Praha, Czech Republic)

    Objective: To distinguish between patients with dystonia according to the clinical outcome of pallidal stimulation (GPi DBS) using intracortical inhibition of the motor cortex assessed…
  • 2016 International Congress

    Long-latency somatosensory evoked potentials of the subthalamic nucleus

    C. Trenado, S. Elben, L. Friggemann, S. Gruhn, S. Groiss, J. Vesper, A. Schnitzler, L. Wojtecki (Düsseldorf, Germany)

    Objective: This study aims to clarify the role of the STN, previously suggested as an integrative component in the control of the basal ganglia-thalamocortical circuit,…
  • 2016 International Congress

    Toward clinical use of electrode localizations in deep brain stimulation therapy

    S. Ewert, A. Horn, P. Plettig, M. Ruch, A. Kühn (Berlin, Germany)

    Objective: To develop an open source software capable of performing electrode localizations certified for clinical use in deep brain stimulation therapy. Background: Deep brain stimulation…
  • 2016 International Congress

    A cognitive monitoring program for individuals with Parkinson’s disease submitted to deep brain stimulation

    L. Fontão, R. Barreto, L. Ruano, A. Sousa, A.I. Martins, A. Costa, A. Aires, C. Sousa, J. Lima, J. Pais, M.J. Rosas, R. Vaz, V.T. Cruz (Santa Maria da Feira, Portugal)

    Objective: Evaluate the feasibility to serially assess cognitive performance with a new self-administered web-based test after DBS. Background: Deep brain stimulation (DBS) has become the…
  • 2016 International Congress

    Impact of the combined depletion of monoamines on the effectiveness of deep brain stimulation of the subthalamic nucleus

    A. Benazzouz, C. Delaville, E. Faggiani (Bordeaux, France)

    Objective: To investigate the involvement of combined depletions of dopamine, norepinephrine and serotonin in the manifestation of motor and non-motor deficits and their impact on…
  • 2016 International Congress

    Is awake intraoperative mapping still necessary for bilateral subthalamic stimulation for Parkinson’s disease in a modern surgical environment?

    Y. Zouitina, M. Lefranc, P. Merle, O. Godefroy, M. Tir, P. Krystkowiak (Amiens, France)

    Objective: To study the impact of the absence of awake clinical evaluation during subthalamic nucleus (STN) deep brain stimulation (DBS) on parameters of stimulation and…
  • 2016 International Congress

    The subthalamic nucleus activity during gait in Parkinson’s disease

    A. Leporini, G. Arnulfo, N.G. Pozzi, C. Palmisano, J. Brumberg, A. Canessa, C.A. Frigo, G. Pezzoli, F. Steigerwald, J. Volkmann, I.U. Isaias (Wuerzburg, Germany)

    Objective: To investigate the activity of the subthalamic nucleus (STN) during gait in subjects with Parkinson's disease (PD). Background: Gait disturbance is a key component…
  • 2016 International Congress

    Effectiveness of bilateral pallidal deep brain stimulation in a patient with dystonia associated to neurodegenerative ataxia: Follow-up to 18 months

    P.A. Millan, J.M. Cardenas (Cali, Colombia)

    Objective: CASE REPORT Background: The dystonia like others movement disorder may be included in neurodegenerative ataxia syndrome, in addition to cerebellar dysfunction. The pallidal stimulation…
  • 2016 International Congress

    Serum brain-derived neurotrophic factor as an indication of disease state in parkinsonism and RBD

    K. Csencsits-Smith, J. Suescun, A. Gonzalez, A. Actor, M. Schiess (Houston, TX, USA)

    Objective: Evaluation of peripheral concentrations of brain-derived neurotrophic Factor (BDNF) in patients with Parkinsonian disorders and correlation with clinical measurements of disease progression to elucidate…
  • 2016 International Congress

    Quantitative assessment of advanced therapies in Parkinson’s disease using the Parkinson kinetigraph (PKG)

    R.L. Blaze, J. Tan, A.H. Evans (Parkville, Australia)

    Objective: Our aim was to establish whether objective measurements using the Parkinson's Kinetigraph can detect differences between patients undergoing different advanced therapy with either deep…
  • « Previous Page
  • 1
  • …
  • 174
  • 175
  • 176
  • 177
  • 178
  • …
  • 187
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley